RxDoctor Payments DataLook up a doctor →

Aloke Finn, MD

Interventional Cardiology · Baltimore, MDNPI 1417922147

Payments from drug & device makers

$1,806,104in general payments, 2019–2025

Across 475 payments — averaging $3802.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$807K
  • Boston Scientific$616K
  • Medtronic$104K
  • Cordis US CORP.$89K
  • Surmodics, Inc.$67K
  • Cook Incorporated$29K
  • plus $96K from 20 others
$24in research payments, 2019–2025

Across 1 payment — averaging $23.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Terumo Medical Corporation$24

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,806,104 in reported general payments places this provider in the 95th percentile of 71 interventional cardiology providers in Maryland.

See all interventional cardiology providers in Maryland

Medicare billing

Part B allowed, 2024
$32,276
Medicare patients
82
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →